KMDA
NASDAQ · Biotechnology
Kamada Ltd
$8.76
+0.02 (+0.23%)
Open$8.69
Previous Close$8.74
Day High$8.76
Day Low$8.68
52W High$9.35
52W Low$6.50
Volume—
Avg Volume164.7K
Market Cap500.21M
P/E Ratio22.48
EPS$0.38
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+231.3% upside
Current
$8.76
$8.76
Target
$29.02
$29.02
$25.25
$29.02 avg
$47.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 149.90M | 149.07M | 67.17M |
| Net Income | 19.55M | 17.49M | -1,989,318 |
| Profit Margin | 5.8% | 5.5% | -3.0% |
| EBITDA | 27.36M | 25.85M | -2,803,887 |
| Free Cash Flow | — | — | -2,727,774 |
| Rev Growth | +0.6% | +0.6% | +14.3% |
| Debt/Equity | 0.04 | 0.04 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |